Risk factors for outcome in refractory acute myeloid leukemia patients treated with a combination of fludarabine, cytarabine, and amsacrine followed by a reduced-intensity conditioning and allogeneic stem cell transplantation

Christian Pfrepper, Anne Klink, Gerhard Behre, Thomas Schenk, Georg‐Nikolaus Franke, Madlen Jentzsch, Sebastian Schwind, Haifa Kathrin Al‐Ali, Andreas Hochhaus, Dietger Niederwieser,

Journal of Cancer Research and Clinical Oncology · 2015 · 25 citations · 22 references

DOIFull text

Open access

Concepts

References

22